Manufacturer
Novartis NDC Codes
Finished products listed with the FDA under labeler names that contain “Novartis”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Exjadedeferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | Novartis Pharmaceuticals Corporation | 0078-0470 |
| Fabhaltaiptacopan | Iptacopan hydrochloride 200 mg/1 | CapsuleOral | Novartis Pharmaceuticals Corporation | 0078-1189 |
| Femaraletrozole | Letrozole 2.5 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0249 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 5 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0430 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0431 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0432 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0433 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0434 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 15 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0493 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 25 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0608 |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 35 mg/1 | Capsule, Extended releaseOral | Novartis Pharmaceuticals Corporation | 0078-0609 |
| Gilenyafingolimod hcl | Fingolimod hydrochloride .5 mg/1 | CapsuleOral | Novartis Pharmaceuticals Corporation | 0078-0607 |
| Gilenyafingolimod hcl | Fingolimod hydrochloride .25 mg/1 | CapsuleOral | Novartis Pharmaceuticals Corporation | 0078-0965 |
| Gleevecimatinib mesylate | Imatinib mesylate 100 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-0401 |
| Gleevecimatinib mesylate | Imatinib mesylate 400 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-0649 |
| Gleevecimatinib mesylate | Imatinib mesylate 400 mg/1 | TabletOral | Novartis Pharmaceuticals Corporation | 0078-1490 |
| Hycamtintopotecan hydrochloride | Topotecan hydrochloride 4 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Novartis Pharmaceuticals Corporation | 0078-0674 |
| Ilariscanakinumab | Canakinumab 150 mg/mL | Injection, SolutionSubcutaneous | Novartis Pharmaceuticals Corporation | 0078-0734 |
| Ilevronepafenac | Nepafenac 3 mg/mL | Suspension/ dropsOphthalmic | Novartis Pharmaceuticals Corporation | 0078-0743 |
| Itvismaonasemnogene abeparvovec-brve | Onasemnogene abeparvovec 40000000000000 [arb'U]/mL | Injection, SuspensionIntrathecal | Novartis Innovative Technologies Inc. | 71894-200 |
| Jadenudeferasirox | Deferasirox 90 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0654 |
| Jadenudeferasirox | Deferasirox 180 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0655 |
| Jadenudeferasirox | Deferasirox 360 mg/1 | Tablet, Film coatedOral | Novartis Pharmaceuticals Corporation | 0078-0656 |
| Jadenudeferasirox | Deferasirox 180 mg/1 | GranuleOral | Novartis Pharmaceuticals Corporation | 0078-0713 |
| Jadenudeferasirox | Deferasirox 360 mg/1 | GranuleOral | Novartis Pharmaceuticals Corporation | 0078-0720 |